Research Presentation Sessions: Interventional Radiology

RPS 2009 - Interventional oncology (part 2)

Lectures

1
Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?

Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?

07:00Hannah Steinberg, Essen / DE

2
Combination of TARE and extrahepatic TACE to treat HCC with extrahepatic artery supply: a case series

Combination of TARE and extrahepatic TACE to treat HCC with extrahepatic artery supply: a case series

07:00Laetitia Saccenti, Paris / FR

3
Factors impacting survival after transarterial radioembolisation in hepatocellular carcinoma: results from the prospective CIRT study

Factors impacting survival after transarterial radioembolisation in hepatocellular carcinoma: results from the prospective CIRT study

07:00Thomas K. Karl Helmberger, Munich / DE

4
CT hepatic arteriography with hybrid angio-CT system during TACE: a strategy to overcome respiratory motion in patients without breath-hold

CT hepatic arteriography with hybrid angio-CT system during TACE: a strategy to overcome respiratory motion in patients without breath-hold

07:00Hyojoo Kim, Iksan-si / KR

5
Selective internal radiation therapy (SIRT) trends for hepatocellular carcinoma, cholangiocarcinoma and liver metastasis: a total population analysis from 2006 to 2020 in Germany

Selective internal radiation therapy (SIRT) trends for hepatocellular carcinoma, cholangiocarcinoma and liver metastasis: a total population analysis from 2006 to 2020 in Germany

07:00Smita Thoduka, Dresden / DE

6
Tumour enhancement analysis on post-procedural Cone Beam CT after DEB-TACE and TAE for hepatocellular carcinoma: evaluation of response and progression

Tumour enhancement analysis on post-procedural Cone Beam CT after DEB-TACE and TAE for hepatocellular carcinoma: evaluation of response and progression

07:00Sergio Parisi, Catania / IT

7
DEB-TACE with LUMI and SeQure anti-reflux microcatheter for the treatment of HCC

DEB-TACE with LUMI and SeQure anti-reflux microcatheter for the treatment of HCC

07:00Giuseppe Pellegrino, Milan / IT

8
Difference between c-TACE and degradable starch microspheres (DSM-TACE) in the treatment of intermediate HCC: experience from a tertiary centre

Difference between c-TACE and degradable starch microspheres (DSM-TACE) in the treatment of intermediate HCC: experience from a tertiary centre

07:00Carolina Lanza, Milan / IT

9
Transpulmonary chemoembolisation (TPCE) of unresectable lung metastases: tumour response and survival time

Transpulmonary chemoembolisation (TPCE) of unresectable lung metastases: tumour response and survival time

07:00Thomas J. Vogl, Frankfurt a. Main / DE

10
What have we learned in more than 10 years of ablation of osteoid osteoma using Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS)?

What have we learned in more than 10 years of ablation of osteoid osteoma using Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS)?

07:00Francesco Arrigoni, L'Aquila / IT

11
Combination therapy of lipiodol based transarterial embolisation and microwave ablation versus microwave ablation as monotherapy for early-stage hepatocellular carcinoma: a comparative study

Combination therapy of lipiodol based transarterial embolisation and microwave ablation versus microwave ablation as monotherapy for early-stage hepatocellular carcinoma: a comparative study

07:00Hamzah Adwan, Frankfurt am Main / DE

12
Moderation

Moderation

00:00Sana Boudabbous, Geneva / CH

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.